Dr Russell Laurence Tuverson Jr, MD in Bristol, CT - Preventive Medicine

Dr Russell Laurence Tuverson Jr, MD is a Preventive Medicine - Occupational Medicine physician based in Bristol, Connecticut. Dr Russell Laurence Tuverson Jr is licensed to practice in Connecticut (license number 021636) and his current practice location is 975 Farmington Ave, Bristol, Connecticut. He can be reached at his office (for appointments etc.) via phone at (860) 589-0114.

NPI number for Dr Russell Laurence Tuverson Jr is 1508920588 and his current mailing address is 975 Farmington Ave, Bristol, Connecticut. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1508920588.

Contact Information

	Dr Russell Laurence Tuverson Jr, MD
	975 Farmington Ave, Bristol, CT 06010
	(860) 589-0114
	(860) 589-1936

Physician's Profile

Full Name	Dr Russell Laurence Tuverson Jr
Gender	Male
Speciality	Preventive Medicine - Occupational Medicine
Location	975 Farmington Ave, Bristol, Connecticut
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1508920588
Provider Enumeration Date: 12/21/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Russell Laurence Tuverson Jr such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1508920588	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2083X0100X	Preventive Medicine - Occupational Medicine	021636 (Connecticut)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Russell Laurence Tuverson Jr is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Russell Laurence Tuverson Jr, MD 975 Farmington Ave, Bristol, CT 06010 Ph: (860) 589-0114	Dr Russell Laurence Tuverson Jr, MD 975 Farmington Ave, Bristol, CT 06010 Ph: (860) 589-0114

News Archive

Pillcam enables Jefferson Physicians to diagnose diseases of esophagus without using endoscope

Most digestive disease specialists will tell you that patients would rather suffer from heartburn and other diseases of the upper GI system than undergo a very effective but also potentially uncomfortable and relatively invasive procedure to diagnose their problem.

Court of Appeals denies McNeil Pediatrics' CONCERTA patent appeal

The Court of Appeals for the Federal Circuit has denied an appeal by McNeil Pediatrics, a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., to overturn a 2009 decision by the U.S. District Court of Delaware that the patent for CONCERTA (methylphenidate HCl) Extended-Release Tablets CII is invalid and not infringed by Andrx Corporation.

DOE program to develop new imager for improving reliability of cancer therapy using heavy-ion beams

In 2008 the Nuclear Science Division (NSD) of the U.S. Department of Energy's Lawrence Berkeley National Laboratory launched the Applied Nuclear Physics program, headed by NSD's Kai Vetter upon his return to Berkeley after six years with Lawrence Livermore National Laboratory. One of the goals of Applied Nuclear Physics is to take experimental principles and equipment created for basic research and develop them into tools that can address practical needs like cancer therapy and homeland security.

Ineffective communication contributes to poor drug adherence

Even the best medicines in the world can be rendered ineffective if they are not taken as prescribed. The problem known as medication "non-adherence" is a major health issue in the United States, contributing to worse outcomes for people who have diabetes and other chronic diseases.

Celldex Therapeutics reports net loss of $13.5M for fourth-quarter of 2009

Celldex Therapeutics, Inc. today reported financial results for the fourth quarter and year ended December 31, 2009. Celldex reported a net loss of $13.5 million, or $0.43 per share, for the fourth quarter of 2009 compared to a net loss of $7.5 million, or $0.47 per share, for the fourth quarter of 2008.

Dr Russell Laurence Tuverson Jr, MD - Preventive Medicine in Bristol, CT